Want to join the conversation?
$DRI posted improved earnings in 1Q17, helped by higher sales and operating income compared to 1Q16. Earnings from continuing operations were $111.1MM or $0.88 per diluted share compared to $81MM or $0.63 per diluted share last year. Total sales from continuing operations grew 1.6% from last year to $1.71Bil. Adjusted diluted net EPS was $0.88.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)